Background
==========

Recent advances in surgical techniques have helped to optimize the outcome of pancreatic surgery, reducing mortality rates to *3-5%*\[[@B1]-[@B4]\]. In the last 20 years several studies have focused on distal pancreatectomy, which accounts for up to *10%* of all pancreatic resections \[[@B5]\]. The main cause of postoperative morbidity in surgery of the distal pancreas is pancreatic fistulas (*30%*) \[[@B2],[@B4],[@B6],[@B7]\]. Despite the advantages of laparoscopic distal pancreatectomy with reduction of postoperative pain, wound infection rates, and intraoperative blood loss, there are no significant differences in the rate of pancreatic fistulas when compared to open surgery \[[@B8]-[@B10]\]. In this context, many different surgical techniques for pancreatic resection and closure of the resection margin were described, such as closure by stapler with or without suture, pancreaticoenteric anastomoses with various modifications, mesh-application, or closure with fibrin glue. None of these techniques were superior concerning the rate of pancreatic fistulas \[[@B1],[@B5],[@B6],[@B11]\].

The aim of this study was to evaluate, whether coverage of the resection margins after distal pancreatectomy reduced postoperative fistulas in our hands.

Methods
=======

We retrospectively analysed all patients receiving a distal pancreatic resection at our department between 2001 and 2011. We compared age, gender, diagnosis; postoperative complications, revision surgery and hospital stay in patients with coverage of the distal pancreatic margin (C) versus those without (NC). Ethical approval is not needed.

The indication for a covered stump was met by the surgeon - on personal discretion and if there was a soft pancreatic remnant.

In all cases -- after mobilization and transection of the pancreatic tail -- the resection margin was closed with monofil 4×0 PDS with separate sutures of the pancreatic duct. In some patients of the no cover-group, fibrin glue or a fibrinogen fleece was placed on the area of resection. For coverage of the resection margins, either the posterior gastric wall, or part of the omentum majus were fixed to the pancreatic tissue. In cases of gastric coverage, a small gastric serosal patch was performed. All patients received a drainage, which remained until suspension of high amylase fluid secretion. During laparoscopic surgery the remnant pancreas was closed with a stapler.

Pancreatic fistulas were primarily treated conservatively, either by leaving the intraoperatively drainage in place or by insertion of a new computed tomography (CT)-guided drainage. Pancreatic fistulas were defined using the classification of ISGPF, claiming a three-fold increase in amylase concentration of the drained secretion compared to the serum amylase at the third postoperative day. Clinically, three levels of pancreatic fistulas, A, B and C, were differentiated as defined by Bassi et al. \[[@B12]\].

Descriptive statistics were used to analyse the variables: differences between groups were statistically evaluated using either Fisher's exact test (categorical variables) or Mann--Whitney U test (metric variables). *p* values of less than *0.05* were considered as statistically significant.

Results
=======

Between 2001 and 2011, 74 patients underwent a distal pancreatectomy with (n=42) or without (n=32) coverage of the resection margin. In 42 of 74 patients (*57%*) the resection margin was closed either by patching it to the gastric wall (n=35, *83%*), or by attaching part of the omentum majus (n=7, *17%*) (C). In 32 of 74 patients (*43%*) there was no coverage of the resection margin (NC) besides direct suture or fibrin glue, as described above. The median age was 53 years in the cover-group (range 25--88 years) and 54 years in no cover-group (range 30--80 years), respectively. 45 of 74 patients (61%) were female. These parameters were not significantly different between the cover- and no cover-group (see Table [1](#T1){ref-type="table"}).

###### 

Demographic and perioperative data

                                                   **Without cover**   **With gastric cover**   **With omentum majus**         
  ----------------------------------------------- ------------------- ------------------------ ------------------------ -------------
  **Age (years)**                                     54 (30--80)           53 (25--82)              51 (29--88)         *n.s.*^*1*^
  **Gender**                                                                                                             *n.s.*^*2*^
    **Female**                                            18                     21                       6                    
    **Male**                                              14                     14                       1                    
  **Laparoscopic**                                    10, 2 conv.                2                        0                    
  **Hospital stay (days, median, range 6--60)**       13 (6--60)             17 (8--60)              15 (10--24)         *n.s.*^*1*^

Demographic and perioperative data of 74 patients with and without covering. Results were not significantly different using Mann--Whitney and Fisher's exact test.

^1^Mann-Whitney U test, ^2^Fisher's exact test; conv: conversion to open resection.

n.s.: not significant.

The most common indications for surgery were insulinomas (18/74, *24%*), followed by ductal adenocarcinomas of the pancreatic tail (9/74, *12%*), non-single-insulinoma-pancreatogenic-hypoglycemia-syndrome (NSIPHS) (8/74, *11%*), pancreatic cysts (8/74, *11%*), multiple endocrine neoplasia I (MEN I) (7/74, *9%*), and for five patients each (*7%*) pancreatic neuroendocrine neoplasias (pNEN) or intrapancreatic metastasis. Indications were equally distributed between both groups (see Table [2](#T2){ref-type="table"}).

###### 

Indications for surgery

                                             **Total**   **Without cover**   **With gastric cover**   **With omentum majus**
  ----------------------------------------- ----------- ------------------- ------------------------ ------------------------
  Insulinoma                                    18               9                     6                        3
  Ductal adeno-CA                                9            3 (R0)               5 (n=1 R1)                 1 (R0)
  NIPHS                                          8               4                     4                         
  Cyst                                           8               2                     4                        2
  MEN I                                          7               4                     3                         
  NET                                            5               3                     1                        1
  Metastasis                                     5               1                     4                         
  Chronic pancreatitis                           4               1                     3                         
  Malign. Insulinoma                             3               2                     1                         
  Gastronoma                                     2               1                     1                         
  Acute biliary pancreatitis                     1                                     1                         
  MEN IIa                                        1                                     1                         
  Serotoninoma                                   1               1                                               
  Mucinous tumour                                1                                     1                         
  Accessory spleen in the pancreatic tail        1               1                                               

The most common indications for surgery were insulinomas (18/74, 24%).

*CA*, carcinoma.

*MEN*, multiple endocrine neoplasia.

*NET*, neuroendocrine tumour.

*NIPHS*, non-insulinoma-pancreatogen-hypoglycamia-syndroma.

In twelve patients (*16%*) the distal pancreatectomy was performed laparoscopically, in two patients with and in ten patients without coverage of the resection margins. In two cases of this group the laparoscopic procedure had to be converted to an open access: in one patient the preoperative described insulinoma was not detected by laparoscopy, and in the other case the soft resection margin was estimated insufficiently closed, leading to conversion to open resection and coverage (see Table [1](#T1){ref-type="table"}).

R0-resection was achieved in eight of nine patients (*89%*) with a ductal adenocarcinoma of the pancreatic tail. Only a 77-year-old male patient had a R1 resection because of vascular invasion by the tumour.

In 39 of 74 patients (*53%*) we observed no postoperative complications, with 23 patients (*55%*) in the cover-group and 16 patients (*50%*) in the no cover-group (n.s.) (see Table [3](#T3){ref-type="table"}). The most frequent complications were pancreatic fistulas in eleven patients (*15%*), bleeding in nine patients (*12%*), of which four (*44%*) needed operative revision, and pneumonia in eight patients (*11%*). Patients of the no cover-group showed a higher frequency of pancreatic fistulas as compared to those of the cover-group (7/32 (*22%*) versus 4/42 (*10%*) (n.s.). Seven of eleven patients with a pancreatic fistula were asymptomatic, just detecting high amylase levels in the drainage (ISGPF A). Three of eleven patients suffered from a pancreatic fistula ISGPF B, and one patient with a persistent pancreatic fistula (ISGPF C) had to be reoperated. Postoperative bleeding occurred in both groups with similar frequency (5/42, *12%* versus 4/32, *13%*) (n.s.).

###### 

Complications

                                         **Without cover**   **With gastric cover**   **With omentum majus**   **Total**         
  ------------------------------------- ------------------- ------------------------ ------------------------ ----------- -------------
  No complications                           16 (50%)               17 (49%)                 6 (86%)              39       *n.s.*^*2*^
  Complications                              16 (50%)               18 (51%)                    1                 35       *n.s.*^*2*^
  Fistula                                     7(22%)                4 (11%)                                       11       *n.s.*^*2*^
    ISGPF A                                      5                     2                                                  
    ISGPF B                                      2                     1                                                  
    ISGPF C                                      0                     1                                                  
  Bleeding                                       4                     4                        1                  9       *n.s.*^*2*^
  Pneumonia                                      1                     7                                           8       *n.s.*^*2*^
  Pancreatitis                                   0                     3                                           3       *n.s.*^*2*^
  Pseudocyst                                     1                     2                                           3       *n.s.*^*2*^
  Splenic infarction                             2                                                                 2       *n.s.*^*2*^
  Abscess                                                              1                                           1       *n.s.*^*2*^
  Small bowel fistula                            1                                                                 1       *n.s.*^*2*^
  Perforation of the colon sigmoideum            1                                                                 1       *n.s.*^*2*^

The most common complications were pancreatic fistulas in 11 patients (15%), and 9 patients (12%) developed postoperative bleeding. Statistical differences between the groups were not significant using Fisher's exact test.

ISGPF: Postoperative pancreatic fistula: an international study group (ISGPF) definition.

^2^Fisher's exact test; n.s.: not significant.

Rarer complications included pancreatitis or pancreatic pseudocysts (three patients each), splenic infarction (two cases), pancreatic abscess, small bowel fistula, and iatrogenic perforation of the colon sigmoideum (one case each) (see Table [3](#T3){ref-type="table"}).

No patient died within the first 30 days after surgery. One patient died due to sepsis following multiple organ failure at day 72 after surgery. This patient with a malignant serotoninoma of the pancreas had liver metastases (TNM pT2 pN1 M1 V1 G2) and a complicated postoperative course with a small bowel fistula, severe pneumonia, and splenic infarction two months after initial surgery.

Six of 74 (*8%*) patients had to undergo revision surgery. Main indication for revision was postoperative bleeding \[two patients in each group (*5%*)\]. Reasons for postoperative bleeding were a diffuse bleeding in the area of resection margin (n=2), a factor XIII deficiency (n=1), and a diffuse bleeding in the area of the ligamentum falciforme (n=1), respectively.

One patient without coverage had to be reoperated on due to a small bowel fistula. In one patient with a gastrinoma and neuroendocrine tumours of the pancreas in MEN I, resurgery was neccessary two months after distal pancreatectomy because of a persistent fistula despite conservative treatment.

Pseudocysts occurred in three patients, with no revision necessary.

The median hospital stay was 16.5 days for all patients (range 6--60) and was shorter in patients in the no cover-group (13 days) as compared to those in the cover-group (17 days) (see Table [1](#T1){ref-type="table"}). This was not significant.

The outcome of our retrospective analysis showed no significant difference in the fistula rate after covering of the resection margin after distal pancreatectomy.

Discussion
==========

Nowadays in experienced hands pancreatic resection has a low mortality rate of less than *5%*\[[@B1]-[@B4]\]. In the current literature, a morbidity rate of *30-50%* is reported, with pancreatic fistulas followed by bleeding and infection as the main causes \[[@B2],[@B4]-[@B7]\].

Also in our patients, pancreatic fistula was the most common postoperative complication. Nevertheless, our study reported a rather low rate of pancreatic fistulas (*15%*) as compared to the experiences of other groups (*12-30%*) (see Table [4](#T4){ref-type="table"}) \[[@B2]-[@B4],[@B6],[@B8]-[@B10],[@B13]-[@B15]\]. Moreover, our analysis revealed a lower frequency of post-operative fistulas in patients undergoing coverage of resection margins (C, 10*11%)* as compared to patients undergoing surgery without coverage (NC, *22%)*, yet without reaching statistical significance (see Table [3](#T3){ref-type="table"}). Notably, all except one patient with a persistent pancreatic fistula could be treated conservatively. Since the drain management and removal was not defined in this study, the overall and detailed fistula rate might be biased.

###### 

Rates of pancreatic fistula (in %) after distal pancreatectomy

  **Author**         **Year**   **Group size**   **Procedures**                                     
  ------------------ ---------- ---------------- ---------------- ---- ------------------ ---- ---- ---
  Present study      2012       74                                22                      11   17   0
  Limongelli         2012       52                                     20 (comb)               18    
  Hackert            2011       98                                13   21 (enucleation)              
  Diener             2011       352 (21c)        32               28                                 
  Song               2011       359                                                            38   4
  Kim                2008       128                               14                           9     
  Pugliese           2008       14                                                             29   0
  Kleef              2007       302              16               9                       8          
  Bilimoria          2003       126              20               22   10 (PDL)                      
  34 (without PDL)                                                                                  
  Adam               2001       41                                29                      7          
  Suzuki             1999       58                                     4 (UD+ PDL)                   
  26 (CV)                                                                                           

Table four compares the rates of pancreatic fistula (in %) after distal pancreatectomy with other works.

c: centers; comb: combined techniques (ultrasonic dissection, sutures, staples, sutures and combinations); *PDL*, pancreatic duct ligation; *UD*, ultrasonic dissection; *CV*, conventional.

Furthermore we did not define or rule out the perioperative use of octreotide, which could be another form of potential bias in this retrospective analysis.

Due to the limited number of patients included in our analysis conclusions about the impact of diagnosis, comorbidities, or over-all patient outcomes were limited and not drawn.

In recent years also other groups focussed on the effect of coverage of the pancreatic stump on the frequency of postoperative pancreatic fistula, yet also without gaining clear results. In our opinion, the influence of personal experience and skill seems to surpass the impact of various technical approaches.

Different other surgical techniques have been described to minimize the rate of postoperative pancreatic fistulas, which varies between *7%* and *33%*\[[@B2]-[@B4],[@B8],[@B11]\]. Besides the limitation that due to the inhomogeneity of patient groups and procedures being compared a assessment of published studies on this topic is difficult but it seems that no method could demonstrate clear superiority to others.

While Kleef et al. described an increased incidence of pancreatic fistulas after stapler closure (*15.9%* in the stapler group versus *9.3%* in the suture group versus *0%* in the pancreaticojejunostomy group), other studies could not verify this finding (see Table [4](#T4){ref-type="table"}) \[[@B1],[@B2],[@B6],[@B11],[@B13],[@B14]\]. Down this line no difference in the rate of pancreatic fistulas when comparing suture and stapler method or a combination of both could be proven \[[@B1],[@B5],[@B6]\].

Laparoscopic distal pancreatectomy failed to reduce the rate of pancreatic fistulas significantly, with rates of *9-18%* versus *14-20%* for open procedures \[[@B8]-[@B10],[@B16]-[@B19]\]. This corresponds to our own results, with a rate of *17%* for laparoscopic resection versus *22%* for open distal pancreatectomy.

Other groups showed reduced rates of pancreatic fistulas by varying the operative technique, but data were not generated by prospective randomized trials. In these prospective and retrospective analyses stapler-closure, placement of a drainage and covering of the pancreatic stump by stomach and fibrin reduced the rate of pancreatic fistulas from *38%* to *4%*\[[@B9]\]. These findings are in line with our experiences, demonstrating that coverage of the pancreatic margin resulted in a tendency toward a reduced rate of pancreatic fistulas (10*11%* versus *22%*). The selective ligation of the pancreatic duct was shown to reduce the rate of pancreatic fistulas to less than *5-10%*\[[@B14],[@B15]\]. Yet, neither of the discussed studies nor our study presented here fulfils the requirements of prospective randomised trials.

Another important point was that the overall fistula rate was 15%, which clearly differs from the overall fistula rate of randomized multicentre trials. It might be that this significantly lower fistula rate is due to the small sample size of this series, biased outcome assessment as outlined above or due to a special, superior surgical technique and perioperative care. This significant discrepancy leads to an impaired comparability with current randomized collectives, which impairs the interpretative power of these results.

Conclusion
==========

Additional covering of the pancreatic stump using sutures does not add any benefit and, therefore, will not be required.
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